ACUTE MYELOID LEUKAEMIA RECURRENT side effect
What is ACUTE MYELOID LEUKAEMIA RECURRENT ?Drugs associated with ACUTE MYELOID LEUKAEMIA RECURRENT
BUSULFAN CEREZYME CLOLAR CYCLOSPORINE CYTARABINE DECITABINE EXJADE FLAGYL FLUOXETINE NEORAL PROGRAFACUTE MYELOID LEUKAEMIA RECURRENT : Cytarabine Side Effects Report #5678119-7
Physician from INDIA reported CYTARABINE problem on Mar 13, 2008. Male patient, 17 years of age, was diagnosed with acute myeloid leukaemia, prophylaxis against graft versus host disease and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia recurrent, bone marrow failure, febrile neutropenia, fungal infection, graft versus host disease, karyotype analysis abnormal, mutagenic effect, no therapeutic response, stem cell transplant, . CYTARABINE dosage: 100 MG/M2. During the same period patient was treated with IDARUBICIN, BUSULPHAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE, METHOTREXATE. Patient recovered.
ACUTE MYELOID LEUKAEMIA RECURRENT : Prograf Side Effects Report #5633645-1
PROGRAF problem was reported by a Physician from UNITED STATES on Feb 08, 2008. Male patient, 58 years of age, was diagnosed with stem cell transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia recurrent, alanine aminotransferase increased, aspartate aminotransferase increased, bacteria blood identified, blood creatinine increased, blood ph increased, blood urea increased, chills, clostridial infection, . PROGRAF dosage: unknown. During the same period patient was treated with PREDNISONE. Patient was hospitalized. Patient died.
ACUTE MYELOID LEUKAEMIA RECURRENT : Busulfan Side Effects Report #5523800-3
Consumer or non-health professional from JAPAN reported BUSULFAN problem on Nov 05, 2007. Male patient, child 4 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia recurrent, graft versus host disease, sepsis, stomatitis, . BUSULFAN dosage: 9.63 ML; QD; IV, 12.84 ML; QD; IV, 3.21 ML; QD; IV. During the same period patient was treated with CYCLOPHOSPHAMIDE, CYTARABINE, CLONAZEPAM, NEUPOGEN, METHOTREXATE. Patient was hospitalized. Patient died on 07/26/2007.
ACUTE MYELOID LEUKAEMIA RECURRENT : Clolar Side Effects Report #5480410-4
CLOLAR problem was reported by a Pharmacist from UNITED STATES on Oct 04, 2007. Female patient, 47 years of age, weighting 185.2 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia recurrent, blood culture positive, candidiasis, ejection fraction decreased, febrile neutropenia, hyperbilirubinaemia, nephrotic syndrome, renal failure, respiratory distress, . CLOLAR dosage: 81MG QD X5 DAYS IV. Patient was hospitalized. Patient recovered.
ACUTE MYELOID LEUKAEMIA RECURRENT : Cytarabine Side Effects Report #5456652-0
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Sept 17, 2007. Male patient, weighting 173.7 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia recurrent, arthritis bacterial, febrile neutropenia, . CYTARABINE dosage: 4000 MG. Patient was hospitalized. Patient recovered.
ACUTE MYELOID LEUKAEMIA RECURRENT : Flagyl Side Effects Report #5422253-3
FLAGYL problem was reported by a Consumer or non-health professional from on Aug 14, 2007. Male patient, 17 years of age, was treated with FLAGYL. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia recurrent, arrhythmia, bronchopulmonary aspergillosis, cardio-respiratory arrest, cerebellar syndrome, coma, convulsion, decerebration, eye movement disorder, . FLAGYL dosage: unknown. During the same period patient was treated with CERUBIDINE, ARACYTINE, NOVANTRONE, AMSIDINE, TAZOCILLINE, AMIKLIN. Patient was hospitalized. Patient died on 06/10/2007.
ACUTE MYELOID LEUKAEMIA RECURRENT : Prograf Side Effects Report #5403437-7
Physician from JAPAN reported PROGRAF problem on July 19, 2007. Male patient, 49 years of age, was diagnosed with bone marrow transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia recurrent, csf test abnormal, viith nerve paralysis, . PROGRAF dosage: unknown. Patient died.
ACUTE MYELOID LEUKAEMIA RECURRENT : Prograf Side Effects Report #5403437-7
PROGRAF problem was reported by a Physician from JAPAN on July 19, 2007. Male patient, 49 years of age, was diagnosed with bone marrow transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia recurrent, csf test abnormal, viith nerve paralysis, . PROGRAF dosage: unknown. Patient died.
ACUTE MYELOID LEUKAEMIA RECURRENT : Busulfan Side Effects Report #5663404-5
Consumer or non-health professional from JAPAN reported BUSULFAN problem on Feb 22, 2008. Male patient, 46 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, acute myeloid leukaemia recurrent, anorexia, convulsion, diarrhoea, nausea, staphylococcal sepsis, stomatitis, . BUSULFAN dosage: 27 ML; 36 ML; 9 ML. Patient was hospitalized. Patient died.
ACUTE MYELOID LEUKAEMIA RECURRENT : Cytarabine Side Effects Report #5678113-6
CYTARABINE problem was reported by a Health Professional from AUSTRALIA on Mar 13, 2008. Female patient, 53 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, acute myeloid leukaemia recurrent, ataxia, dysarthria, impaired gastric emptying, nausea, nervous system disorder, neurotoxicity, oral intake reduced, . CYTARABINE dosage: 100 MG/M2 DAILY. During the same period patient was treated with IDARUBICIN. Patient recovered.
ACUTE MYELOID LEUKAEMIA RECURRENT : Fluoxetine Side Effects Report #5678407-4
Pharmacist from UNITED STATES reported FLUOXETINE problem on Mar 10, 2008. Male patient, 23 years of age, was diagnosed with affective disorder and was treated with FLUOXETINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, acute myeloid leukaemia recurrent, affective disorder, anxiety, attention deficit/hyperactivity disorder, blood culture positive, dyspnoea, . FLUOXETINE dosage: 80 MG; QD; PO. During the same period patient was treated with METHADON, NICOTINE, LORAZEPAM, QUETIAPINE FUMARATE, VORICONAZOLE, CYTARABINE, LINEZOLID. Patient was hospitalized. Patient recovered.
ACUTE MYELOID LEUKAEMIA RECURRENT : Busulfan Side Effects Report #5585758-0
BUSULFAN problem was reported by a Consumer or non-health professional from JAPAN on Dec 21, 2007. Male patient, 64 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, acute myeloid leukaemia recurrent, anorexia, atrial tachycardia, atrioventricular block, bone marrow transplant, cytomegalovirus antigen positive, dysgeusia, hepatic function abnormal, . BUSULFAN dosage: unknown. During the same period patient was treated with PHENYTOIN, NARTOGRASTIM, METHOTREXATE, TACROLIMUS, CYLOCIDE, NOVANTRONE. Patient was hospitalized. Patient recovered.
ACUTE MYELOID LEUKAEMIA RECURRENT : Cyclosporine Side Effects Report #5474025-1
Consumer or non-health professional from JAPAN reported CYCLOSPORINE problem on Sept 27, 2007. Male patient, child 1 years of age, weighting 18.74 lb, was diagnosed with bone marrow transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, acute myeloid leukaemia recurrent, stem cell transplant, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with METHOTREXATE, SANDIMMUNE. Patient died.
ACUTE MYELOID LEUKAEMIA RECURRENT : Neoral Side Effects Report #5487710-2
NEORAL problem was reported by a Consumer or non-health professional from JAPAN on Oct 11, 2007. Male patient, child 1 years of age, weighting 18.74 lb, was diagnosed with bone marrow transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, acute myeloid leukaemia recurrent, stem cell transplant, . NEORAL dosage: unknown. During the same period patient was treated with METHOTREXATE, SANDIMMUNE, ENDOXAN. Patient died.
ACUTE MYELOID LEUKAEMIA RECURRENT : Cyclosporine Side Effects Report #5466581-4
Consumer or non-health professional from JAPAN reported CYCLOSPORINE problem on Sept 19, 2007. Male patient, child 1 years of age, weighting 18.74 lb, was diagnosed with bone marrow transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, acute myeloid leukaemia recurrent, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with METHOTREXATE, SANDIMMUNE. Patient died.
ACUTE MYELOID LEUKAEMIA RECURRENT : Exjade Side Effects Report #5400560-8
EXJADE problem was reported by a Physician from UNITED STATES on July 27, 2007. Male patient, 65 years of age, was diagnosed with iron overload, acute myeloid leukaemia and was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, acute myeloid leukaemia recurrent, atelectasis, blood albumin decreased, blood alkaline phosphatase increased, blood creatinine increased, blood sodium decreased, bronchoscopy normal, cardiac disorder, . EXJADE dosage: 1750 MG, QD. During the same period patient was treated with RED BLOOD CELLS, PLATELETS, NEUPOGEN, LAMIVUDINE, ACYCLOVIR, METOPROLOL SUCCINATE, NORVASC, DILTIAZEM. Patient was hospitalized. Patient died on 06/10/2007.
ACUTE MYELOID LEUKAEMIA RECURRENT : Exjade Side Effects Report #5400560-8
Physician from UNITED STATES reported EXJADE problem on July 27, 2007. Male patient, 65 years of age, was diagnosed with iron overload, acute myeloid leukaemia and was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, acute myeloid leukaemia recurrent, atelectasis, blood albumin decreased, blood alkaline phosphatase increased, blood creatinine increased, blood sodium decreased, bronchoscopy normal, cardiac disorder, . EXJADE dosage: 1750 MG, QD. During the same period patient was treated with RED BLOOD CELLS, PLATELETS, NEUPOGEN, LAMIVUDINE, ACYCLOVIR, METOPROLOL SUCCINATE, NORVASC, DILTIAZEM. Patient was hospitalized. Patient died on 06/10/2007.
ACUTE MYELOID LEUKAEMIA RECURRENT : Decitabine Side Effects Report #5663732-3
DECITABINE problem was reported by a Physician from UNITED STATES on Feb 25, 2008. Female patient, 65 years of age, was diagnosed with acute myeloid leukaemia, pneumonia fungal and was treated with DECITABINE. After drug was administered, patient experienced the following problems/side effects: abdominal hernia, abdominal pain, acute myeloid leukaemia recurrent, diabetes mellitus inadequate control, disease progression, febrile neutropenia, fluid overload, haematocrit decreased, . DECITABINE dosage: 20 MG/M2, IN 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.
ACUTE MYELOID LEUKAEMIA RECURRENT : Cerezyme Side Effects Report #5625442-8
Physician from UNITED STATES reported CEREZYME problem on Feb 05, 2008. Male patient, 60 years of age, weighting 205.0 lb, was diagnosed with gaucher's disease and was treated with CEREZYME. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, acute myeloid leukaemia (in remission), acute myeloid leukaemia recurrent, . CEREZYME dosage: unknown. During the same period patient was treated with FOSAMAX. Patient was hospitalized. Patient recovered.
ACUTE MYELOID LEUKAEMIA RECURRENT : Prograf Side Effects Report #5472216-7
PROGRAF problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 10, 2007. Female patient, 46 years of age, was diagnosed with off label use and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: abscess limb, acute myeloid leukaemia, acute myeloid leukaemia recurrent, anorexia, atrial fibrillation, atrial flutter, blood potassium decreased, catheter site erythema, cellulitis, . PROGRAF dosage: 0.5 MG, BID; ORAL. During the same period patient was treated with CELLCEPT, DACLIZUMAB, ACYCLOVIR, PROTONIX, VFEND, PROVERA, PROCRIT, ALLEGRA. Patient was hospitalized. Patient died on 06/01/2007.